SEI Investments’s Neuronetics STIM Stock Holding History

SEI Investments’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-76,046	Closed	-$110K	–	3398
2026 Q1	$110K	Buy	+76,046	New	+$121K	﹤0.01%	3080
2023 Q3	–	Sell	-19,533	Closed	-$42K	–	2694
2023 Q2	$42K	Hold	19,533	–	–	﹤0.01%	2626
2023 Q1	$56.8K	Buy	19,533 +362	+2%	+$1.82K	﹤0.01%	2618
2022 Q4	$132K	Hold	19,171	–	–	﹤0.01%	2412
2022 Q3	$61K	Hold	19,171	–	–	﹤0.01%	2611
2022 Q2	$62K	Hold	19,171	–	–	﹤0.01%	2596
2022 Q1	$58K	Sell	19,171 -399	-2%	-$1.35K	﹤0.01%	2545
2021 Q4	$87K	Hold	19,570	–	–	﹤0.01%	2552
2021 Q3	$128K	Buy	19,570 +7,633	+64%	+$73.2K	﹤0.01%	2492
2021 Q2	$191K	Buy	+11,937	New	+$165K	﹤0.01%	2453
2018 Q3	–	Sell	-1,580	Closed	-$42K	–	3353
2018 Q2	$42K	Buy	+1,580	New	+$43K	﹤0.01%	2567

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SEI Investments's STIM Position: Q2 2026 in Review

SEI Investments sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 76,046 shares — an estimated $110K sold.

SEI Investments first reported a position in STIM in Q2 2018 and held it in 11 quarters. The position peaked at $191K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

SEI Investments reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
SEI Investments sold 76,046 Neuronetics shares in Q2 2026, an estimated $110K.
SEI Investments first reported a position in Neuronetics in Q2 2018 and held it in 11 quarters.
SEI Investments's Neuronetics position peaked at $191K in Q2 2021.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.